Document is current
Any future updates will be listed below
-
Authors
Allende, Daniela S. https://orcid.org/0000-0001-9868-8269
Guy, Cynthia D.
Kleiner, David E.
Carpenter, Danielle
Gill, Ryan M.
Cummings, Oscar
Contos, Melissa
Yeh, Matthew
Belt, Patricia
Wilson, Laura A.
Van Natta, Mark
Behling, Cynthia
,
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061713)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061718)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061728)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061732)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061734)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061737)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061738)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061730)
National Institute of Diabetes and Digestive and Kidney Diseases (U24DK061730)
National Center for Advancing Translational Sciences (UL1TR000439)
National Center for Advancing Translational Sciences (UL1TR000077)
National Center for Advancing Translational Sciences (UL1TR000436)
National Center for Advancing Translational Sciences (UL1TR000150)
National Center for Advancing Translational Sciences (UL1TR000424)
National Center for Advancing Translational Sciences (UL1TR000006)
National Center for Advancing Translational Sciences (UL1TR000448)
National Center for Advancing Translational Sciences (UL1TR000040)
National Center for Advancing Translational Sciences (UL1TR000100)
National Center for Advancing Translational Sciences (UL1TR000004)
National Center for Advancing Translational Sciences (UL1TR000423)
National Center for Advancing Translational Sciences (UL1TR002649)
National Center for Advancing Translational Sciences (UL1TR000454)
- License Information
-
More Information
Article History
Received: 8 November 2024
Revised: 8 March 2025
Accepted: 23 March 2025
First Online: 10 April 2025
Declarations
:
: Dr. Behling’s institution provides contract services for ICON, Covance and Sharp Healthcare Laboratories. Dr. Behling has received speaker fees from Pfizer and Alimentiv for NASH related topics.Dr. Allende has received a one-time honorarium from Mayo Clinic, Univ. of Ottawa and Educational Symposia.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
